Dr. Cui's research is focused on drug and vaccine delivery.
Improving the efficacy of anticancer drugs and overcoming tumor chemoresistance using nanotechnology
Skin protects not only by acting as a physical barrier, but also by its role in our powerful immune system. As a frontline of defense against pathogens, skin is well equipped for immune surveillance. Thus, targeting antigens to the skin epidermis can induce strong immune responses. However, the forbidden barrier posed by the stratum corneum layer in the epidermis prevents the entrance of vaccine antigens into the epidermis. Non-invasive transcutaneous immunization onto the skin is an attractive immunization modality, but the immune responses induced are generally weak. We are interested in enhancing the immune responses induced by transcutaneous immunization by modifying the hair follicle cycle or using microneedles.
University of Kentucky, Ph.D., Pharmaceutics, 2002
College of Pharmacy
The University of Texas
2409 University Ave.
Austin, TX, USA
Email Address: pharmacy
Enhancing drug-delivery technologies can help in curing and treating diseases such as cancer, cardiovascular diseases, diabetes, fungal, respiratory and infectious diseases and treatment after organ transplants to prevent rejection.